Priority for atypical antipsychotic drugs? Current studies clarify the issues;Priorität für Atypika? Aktuelle Studien rücken einiges zurecht.

Psychiatrische Praxis

Volumn 34, Issue 1, 2007, Pages 46-49

  Dose, Matthias ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CHRONIC DISEASE; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HUMAN; LETTER; PATIENT; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICS; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; HUMANS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34247871345     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-959065     Document Type: Letter

References (0)